Colorectal Cancer Essential Panel – LB

Test Code
SLS162601

What is the Colorectal Cancer Essential Panel - Liquid Biopsy?

This liquid biopsy test evaluates genetic changes in 7 genes associated with colorectal cancer using a blood sample. It identifies SNVs, CNVs, and InDels, providing crucial information to guide therapy.

Genes Covered/ No. of Genes: 7 genes

Who Is This Test For?

Colorectal cancer patients who are unable to undergo tissue biopsy, or need a minimally invasive option for treatment planning or monitoring, where real-time assessment of tumor evolution or resistance is necessary

Key Features

  • Detects SNVs, InDels, and CNVs in 7 clinically relevant genes for colorectal cancer
  • Non-invasive method, requires a simple blood draw

Clinical Applications

  • Identifies actionable mutations and eligibility for targeted therapies
  • Monitors for treatment response and disease recurrence
  • Enables molecular testing when tissue is limited or unavailable

Colorectal Cancer

Contact Us